Healthcare Stocks — 540 Companies
Every Healthcare company we hold SEC-filed annual statements for, ordered by market capitalisation. The largest is Akari Therapeutics Plc (AKTX) at $1.67T. 539 of them carry a filed annual revenue figure, shown beside the name. Each entry links to its valuation, financial statements, growth rates and PEG ratio.
- Akari Therapeutics Plc (AKTX)$0.00 revenue · FY2025
- ELI LILLY & Co (LLY)$65.2B revenue · FY2025
- Johnson & Johnson (JNJ)$94.2B revenue · FY2025
- BeOne Medicines Ltd. (ONC)$5.34B revenue · FY2025
- AbbVie Inc. (ABBV)$61.2B revenue · FY2025
- Merck & Co., Inc. (MRK)$65.0B revenue · FY2025
- Unitedhealth Group Inc (UNH)$448B revenue · FY2025
- Novartis AG (NVS)$54.5B revenue · FY2025
- Astrazeneca PLC (AZN)$58.7B revenue · FY2025
- Amgen Inc (AMGN)$36.8B revenue · FY2025
- GSK plc (GSK)GBP 32.7B revenue · FY2025
- Novo Nordisk A S (NVO)DKK 309B revenue · FY2025
- Biodexa Pharmaceuticals Plc (BDRX)GBP 0.00 revenue · FY2025
- Abbott Laboratories (ABT)$44.3B revenue · FY2025
- Gilead Sciences, Inc. (GILD)$29.4B revenue · FY2025
- Pfizer Inc (PFE)$62.6B revenue · FY2025
- Vertex Pharmaceuticals Inc / MA (VRTX)$12.0B revenue · FY2025
- Bristol Myers Squibb Co (BMY)$48.2B revenue · FY2025
- Intuitive Surgical Inc (ISRG)$10.1B revenue · FY2025
- CVS HEALTH Corp (CVS)$402B revenue · FY2025
- Medtronic plc (MDT)$36.4B revenue · FY2026
- Stryker Corp (SYK)$25.1B revenue · FY2025
- Sanofi (SNY)EUR 43.6B revenue · FY2025
- Mckesson Corp (MCK)$403B revenue · FY2026
- HCA Healthcare, Inc. (HCA)$75.6B revenue · FY2025
- Elevance Health, Inc. (ELV)$199B revenue · FY2025
- 3M Co (MMM)$24.9B revenue · FY2025
- Regeneron Pharmaceuticals, Inc. (REGN)$14.3B revenue · FY2025
- Cigna Group (CI)$275B revenue · FY2025
- Boston Scientific Corp (BSX)$20.1B revenue · FY2025
- Bruker Corp (BRKRP)$3.44B revenue · FY2025
- Argenx SE (ARGX)EUR 4.15B revenue · FY2025
- Cencora, Inc. (COR)$321B revenue · FY2025
- Argenx SE (ARGNF)EUR 4.15B revenue · FY2025
- Moderna, Inc. (MRNA)$1.94B revenue · FY2025
- Cardinal Health Inc (CAH)$254B revenue · FY2026
- Takeda Pharmaceutical Co Ltd (TAK)JPY 4.51T revenue · FY2026
- Edwards Lifesciences Corp (EW)$6.07B revenue · FY2025
- Becton Dickinson & Co (BDX)$21.8B revenue · FY2025
- Humana Inc (HUM)$130B revenue · FY2025
- Natera, Inc. (NTRA)$2.31B revenue · FY2025
- Revolution Medicines, Inc. (RVMD)$0.00 revenue · FY2025
- Iqvia Holdings Inc. (IQV)$16.3B revenue · FY2025
- Agilent Technologies, Inc. (A)$6.95B revenue · FY2025
- Teva Pharmaceutical Industries Ltd (TEVA)$17.3B revenue · FY2025
- Idexx Laboratories Inc (IDXX)$4.30B revenue · FY2025
- Waters Corp (WAT)$3.17B revenue · FY2025
- NuCana plc (NCNA)GBP 0.00 revenue · FY2025
- Alnylam Pharmaceuticals, Inc. (ALNY)$3.71B revenue · FY2025
- Alcon Inc (ALC)$10.4B revenue · FY2025
- RedHill Biopharma Ltd. (RDHL)$286K revenue · FY2025
- Dexcom Inc (DXCM)$4.66B revenue · FY2025
- Centene Corp (CNC)$195B revenue · FY2025
- Illumina, Inc. (ILMN)$4.34B revenue · FY2025
- Resmed Inc (RMD)$5.65B revenue · FY2026
- Biogen Inc. (BIIB)$9.89B revenue · FY2025
- Medline Inc. (MDLN)$28.4B revenue · FY2025
- Zoetis Inc. (ZTS)$9.47B revenue · FY2025
- GE HealthCare Technologies Inc. (GEHC)$20.6B revenue · FY2025
- INSMED Inc (INSM)$606M revenue · FY2025
- Mettler Toledo International Inc/ (MTD)$4.03B revenue · FY2025
- Labcorp Holdings Inc. (LH)$14.0B revenue · FY2025
- Quest Diagnostics Inc (DGX)$13.0M revenue · FY2025
- BioNTech SE (BNTX)EUR 2.87B revenue · FY2025
- Incyte Corp (INCY)$5.14B revenue · FY2025
- Roivant Sciences Ltd. (ROIV)$8.26M revenue · FY2026
- Koninklijke Philips NV (PHG)EUR 17.8B revenue · FY2025
- Royalty Pharma plc (RPRX)$2.38B revenue · FY2025
- West Pharmaceutical Services Inc (WST)$3.07B revenue · FY2025
- STERIS plc (STE)$5.94B revenue · FY2026
- Guardant Health, Inc. (GH)$982M revenue · FY2025
- Tenet Healthcare Corp (THC)$21.3B revenue · FY2025
- UNITED THERAPEUTICS Corp (UTHR)$3.18B revenue · FY2025
- Genmab A/S (GMAB)DKK 3.72B revenue · FY2025
- Viatris Inc (VTRS)$14.3B revenue · FY2025
- Zimmer Biomet Holdings, Inc. (ZBH)$8.23B revenue · FY2025
- Ascendis Pharma A/S (ASND)EUR 720M revenue · FY2025
- Medpace Holdings, Inc. (MEDP)$2.53B revenue · FY2025
- Jazz Pharmaceuticals plc (JAZZ)$4.27B revenue · FY2025
- Neurocrine Biosciences Inc (NBIX)$2.86B revenue · FY2025
- Solventum Corp (SOLV)$8.32B revenue · FY2025
- UL Solutions Inc. (ULS)$3.05B revenue · FY2025
- BridgeBio Pharma, Inc. (BBIO)$502M revenue · FY2025
- Exelixis, Inc. (EXEL)$2.32B revenue · FY2026
- Revvity, Inc. (RVTY)$2.86B revenue · FY2025
- Summit Therapeutics Inc. (SMMT)$0.00 revenue · FY2025
- Charles River Laboratories International, Inc. (CRL)$4.02B revenue · FY2025
- Cooper Companies, Inc. (COO)$4.09B revenue · FY2025
- Baxter International Inc (BAX)$11.2B revenue · FY2025
- Biomarin Pharmaceutical Inc (BMRN)$3.22B revenue · FY2025
- Penumbra Inc (PEN)$1.40B revenue · FY2025
- Smith & Nephew PLC (SNN)$6.16B revenue · FY2025
- Fresenius Medical Care AG (FMS)$19.6B revenue · FY2025
- Icon PLC (ICLR)$8.25B revenue · FY2025
- Halozyme Therapeutics, Inc. (HALO)$1.40B revenue · FY2025
- Madrigal Pharmaceuticals, Inc. (MDGL)$958M revenue · FY2025
- Elanco Animal Health Inc (ELAN)$4.71B revenue · FY2025
- Arrowhead Pharmaceuticals, Inc. (ARWR)$829M revenue · FY2025
- Corcept Therapeutics Inc (CORT)$761M revenue · FY2025
- BrightSpring Health Services, Inc. (BTSG)$12.9B revenue · FY2025
- Encompass Health Corp (EHC)$5.94B revenue · FY2025
- Davita Inc. (DVA)$13.6B revenue · FY2025
- BIO-TECHNE Corp (TECH)$1.22B revenue · FY2026
- Align Technology Inc (ALGN)$4.03B revenue · FY2025
- Axsome Therapeutics, Inc. (AXSM)$638M revenue · FY2025
- Bio-Rad Laboratories, Inc. (BIO)$2.58B revenue · FY2025
- Krystal Biotech, Inc. (KRYS)$389M revenue · FY2025
- Globus Medical Inc (GMED)$2.94B revenue · FY2025
- Molina Healthcare, Inc. (MOH)$45.4B revenue · FY2025
- GLAUKOS Corp (GKOS)$507M revenue · FY2025
- Insulet Corp (PODD)$2.71B revenue · FY2025
- Avantor, Inc. (AVTR)$6.55B revenue · FY2025
- Apogee Therapeutics, Inc. (APGE)$0.00 revenue · FY2025
- Structure Therapeutics Inc. (GPCR)$0.00 revenue · FY2025
- Universal Health Services Inc (UHS)$17.4B revenue · FY2025
- Cytokinetics Inc (CYTK)$88.0M revenue · FY2025
- Henry Schein Inc (HSIC)$13.2B revenue · FY2025
- DR Reddys Laboratories Ltd (RDY)INR 336B revenue · FY2026
- Ensign Group, Inc (ENSG)$5.06B revenue · FY2025
- Praxis Precision Medicines, Inc. (PRAX)$0.00 revenue · FY2025
- Kymera Therapeutics, Inc. (KYMR)$39.2M revenue · FY2025
- Oscar Health, Inc. (OSCR)$11.7B revenue · FY2025
- Ionis Pharmaceuticals Inc (IONS)$944M revenue · FY2025
- Repligen Corp (RGEN)$738M revenue · FY2025
- Qiagen N.V. (QGEN)$2.09B revenue · FY2025
- Protagonist Therapeutics, Inc (PTGX)$46.0M revenue · FY2025
- Vaxcyte, Inc. (PCVX)$0.00 revenue · FY2025
- Crinetics Pharmaceuticals, Inc. (CRNX)$7.70M revenue · FY2025
- Abivax S.A. (ABVX)EUR 0.00 revenue · FY2025
- Bruker Corp (BRKR)$3.44B revenue · FY2025
- TG Therapeutics, Inc. (TGTX)$616M revenue · FY2025
- ImmunityBio, Inc. (IBRX)$113M revenue · FY2025
- 10x Genomics, Inc. (TXG)$643M revenue · FY2025
- Immunovant, Inc. (IMVT)$0.00 revenue · FY2026
- Twist Bioscience Corp (TWST)$377M revenue · FY2025
- Alkermes plc. (ALKS)$1.48B revenue · FY2025
- Belite BIO, Inc (BLTE)$0.00 revenue · FY2025
- MSA Safety Inc (MSA)$1.87B revenue · FY2025
- Caris Life Sciences, Inc. (CAI)$812M revenue · FY2025
- Rhythm Pharmaceuticals, Inc. (RYTM)$190M revenue · FY2025
- Chemed Corp (CHE)$2.53B revenue · FY2025
- BioLineRx Ltd. (BLRX)$1.18M revenue · FY2025
- Scholar Rock Holding Corp (SRRK)$0.00 revenue · FY2025
- PACS Group, Inc. (PACS)$5.29B revenue · FY2025
- Grifols SA (GRFS)EUR 7.52B revenue · FY2025
- CG Oncology, Inc. (CGON)$4.04M revenue · FY2025
- Lantheus Holdings, Inc. (LNTH)$1.54B revenue · FY2025
- Mirum Pharmaceuticals, Inc. (MIRM)$521M revenue · FY2025
- MiniMed Group, Inc. (MMED)$3.10B revenue · FY2026
- Bausch & Lomb Corp (BLCO)$5.10B revenue · FY2025
- Hims & Hers Health, Inc. (HIMS)$2.35B revenue · FY2025
- Stevanato Group S.p.A. (STVN)EUR 1.19B revenue · FY2025
- Travere Therapeutics, Inc. (TVTX)$491M revenue · FY2025
- Liquidia Corp (LQDA)$158M revenue · FY2025
- Dianthus Therapeutics, Inc. (DNTH)$2.04M revenue · FY2025
- Kiniksa Pharmaceuticals International, plc (KNSA)$678M revenue · FY2025
- Cogent Biosciences, Inc. (COGT)$0.00 revenue · FY2025
- Teleflex Inc (TFX)$1.99B revenue · FY2025
- RadNet, Inc. (RDNT)$2.04B revenue · FY2025
- Xenon Pharmaceuticals Inc. (XENE)$7.50M revenue · FY2025
- PTC Therapeutics, Inc. (PTCT)$1.73B revenue · FY2025
- Radiopharm Theranostics Ltd (RADX)$3.63M revenue · FY2025
- Ligand Pharmaceuticals Inc (LGND)$268M revenue · FY2025
- Erasca, Inc. (ERAS)$0.00 revenue · FY2025
- Amneal Pharmaceuticals, Inc. (AMRX)$3.02B revenue · FY2025
- CRISPR Therapeutics AG (CRSP)$3.51M revenue · FY2025
- Sotera Health Co (SHC)$1.16B revenue · FY2025
- Merit Medical Systems Inc (MMSI)$1.52B revenue · FY2025
- Definium Therapeutics, Inc. (DFTX)$0.00 revenue · FY2025
- LifeStance Health Group, Inc. (LFST)$1.42B revenue · FY2025
- Acadia Pharmaceuticals Inc (ACAD)$1.07B revenue · FY2025
- Celcuity Inc. (CELC)$0.00 revenue · FY2025
- Haemonetics Corp (HAE)$1.33B revenue · FY2026
- Edgewise Therapeutics, Inc. (EWTX)$0.00 revenue · FY2025
- BillionToOne, Inc. (BLLN)$305M revenue · FY2025
- Dyne Therapeutics, Inc. (DYN)$0.00 revenue · FY2025
- Spyre Therapeutics, Inc. (SYRE)$0.00 revenue · FY2025
- LivaNova PLC (LIVN)$1.39B revenue · FY2025
- Concentra Group Holdings Parent, Inc. (CON)$2.16B revenue · FY2025
- Envista Holdings Corp (NVST)$2.72B revenue · FY2025
- Enliven Therapeutics, Inc. (ELVN)$0.00 revenue · FY2025
- Integer Holdings Corp (ITGR)$1.85B revenue · FY2025
- Heartflow, Inc. (HTFL)$176M revenue · FY2025
- ICU Medical Inc (ICUI)$2.23B revenue · FY2025
- Relay Therapeutics, Inc. (RLAY)$15.4M revenue · FY2025
- Indivior Pharmaceuticals, Inc. (INDV)$1.24B revenue · FY2025
- Veradermics, Inc (MANE)$0.00 revenue · FY2025
- Viking Therapeutics, Inc. (VKTX)$0.00 revenue · FY2025
- iRhythm Holdings, Inc. (IRTC)$747M revenue · FY2025
- Telix Pharmaceuticals Ltd (TLX)$804M revenue · FY2025
- DBV Technologies S.A. (DBVT)$5.64M revenue · FY2025
- Tarsus Pharmaceuticals, Inc. (TARS)$451M revenue · FY2025
- Iovance Biotherapeutics, Inc. (IOVA)$264M revenue · FY2025
- Legend Biotech Corp (LEGN)$1.03B revenue · FY2025
- Oruka Therapeutics, Inc. (ORKA)$0.00 revenue · FY2025
- Adaptive Biotechnologies Corp (ADPT)$277M revenue · FY2025
- IDEAYA Biosciences, Inc. (IDYA)$219M revenue · FY2025
- Option Care Health, Inc. (OPCH)$5.65B revenue · FY2025
- Amylyx Pharmaceuticals, Inc. (AMLX)$0.00 revenue · FY2025
- Pulse Biosciences, Inc. (PLSE)$350K revenue · FY2025
- Tango Therapeutics, Inc. (TNGX)$62.4M revenue · FY2025
- Arcus Biosciences, Inc. (RCUS)$247M revenue · FY2025
- Organon & Co. (OGN)$6.22B revenue · FY2025
- GRAIL, Inc. (GRAL)$147M revenue · FY2025
- Denali Therapeutics Inc. (DNLI)$0.00 revenue · FY2025
- AbCellera Biologics Inc. (ABCL)$75.1M revenue · FY2025
- Scinai Immunotherapeutics Ltd. (SCNI)$1.31M revenue · FY2025
- National Healthcare Corp (NHC)$1.52B revenue · FY2025
- Veracyte, Inc. (VCYT)$517M revenue · FY2025
- Regencell Bioscience Holdings Ltd (RGC)$0.00 revenue · FY2025
- Vicore Pharma Holding AB (VCRE)SEK 3.82M revenue · FY2025
- Purple Biotech Ltd. (PPBT)$0.00 revenue · FY2025
- TransMedics Group, Inc. (TMDX)$605M revenue · FY2025
- Celldex Therapeutics, Inc. (CLDX)$1.54M revenue · FY2025
- Beam Therapeutics Inc. (BEAM)$140M revenue · FY2025
- Disc Medicine, Inc. (IRON)$0.00 revenue · FY2025
- Immunome Inc. (IMNM)$6.94M revenue · FY2025
- NewAmsterdam Pharma Co N.V. (NAMS)$22.5M revenue · FY2025
- Arcutis Biotherapeutics, Inc. (ARQT)$376M revenue · FY2025
- MBX Biosciences, Inc. (MBX)$0.00 revenue · FY2025
- Aveanna Healthcare Holdings, Inc. (AVAH)$2.43B revenue · FY2026
- Zai Lab Ltd (ZLAB)$460M revenue · FY2025
- Brookdale Senior Living Inc. (BKD)$3.19B revenue · FY2025
- Alignment Healthcare, Inc. (ALHC)$3.95B revenue · FY2025
- uniQure N.V. (QURE)$16.1M revenue · FY2025
- SELLAS Life Sciences Group, Inc. (SLS)$0.00 revenue · FY2025
- Warby Parker Inc. (WRBY)$872M revenue · FY2025
- AtaiBeckley Inc. (ATAI)$4.09M revenue · FY2025
- Nurix Therapeutics, Inc. (NRIX)$84.0M revenue · FY2025
- Privia Health Group, Inc. (PRVA)$2.12B revenue · FY2025
- CareDx, Inc. (CDNA)$380M revenue · FY2025
- AtriCure, Inc. (ATRC)$535M revenue · FY2025
- Axogen, Inc. (AXGN)$225M revenue · FY2025
- Acadia Healthcare Company, Inc. (ACHC)$3.31B revenue · FY2025
- Vera Therapeutics, Inc. (VERA)$0.00 revenue · FY2025
- Neogen Corp (NEOG)$870M revenue · FY2026
- GeneDx Holdings Corp. (WGS)$428M revenue · FY2025
- Biocryst Pharmaceuticals Inc (BCRX)$875M revenue · FY2025
- Precigen, Inc. (PGEN)$9.68M revenue · FY2025
- Nektar Therapeutics (NKTR)$55.2M revenue · FY2025
- Supernus Pharmaceuticals, Inc. (SUPN)$719M revenue · FY2025
- Mineralys Therapeutics, Inc. (MLYS)$0.00 revenue · FY2025
- Prestige Consumer Healthcare Inc. (PBH)$1.09B revenue · FY2026
- Harmony Biosciences Holdings, Inc. (HRMY)$868M revenue · FY2025
- Trevi Therapeutics, Inc. (TRVI)$0.00 revenue · FY2025
- HUTCHMED (China) Ltd (HCM)$549M revenue · FY2025
- Bausch Health Companies Inc. (BHC)$10.3B revenue · FY2025
- Nuvation Bio Inc. (NUVB)$62.9M revenue · FY2025
- Sarepta Therapeutics, Inc. (SRPT)$2.20B revenue · FY2025
- Guardian Pharmacy Services, Inc. (GRDN)$1.45B revenue · FY2025
- Biohaven Ltd. (BHVN)$0.00 revenue · FY2025
- Ocular Therapeutix, Inc (OCUL)$52.0M revenue · FY2025
- Trulieve Cannabis Corp. (TRLV)$1.18B revenue · FY2025
- Pharvaris N.V. (PHVS)EUR 0.00 revenue · FY2025
- DENTSPLY SIRONA Inc. (XRAY)$3.68B revenue · FY2025
- Palvella Therapeutics, Inc. (PVLA)$0.00 revenue · FY2025
- Mesoblast Ltd (MESO)$120M revenue · FY2026
- UFP Technologies Inc (UFPT)$603M revenue · FY2025
- Neogenomics Inc (NEO)$727M revenue · FY2025
- Clover Health Investments, Corp. (CLOV)$1.92B revenue · FY2025
- Kodiak Sciences Inc. (KOD)$0.00 revenue · FY2025
- Addus HomeCare Corp (ADUS)$1.42B revenue · FY2025
- Establishment Labs Holdings Inc. (ESTA)$211M revenue · FY2025
- Pediatrix Medical Group, Inc. (MD)$1.91B revenue · FY2025
- Rapport Therapeutics, Inc. (RAPP)$0.00 revenue · FY2025
- Trulieve Cannabis Corp. (TCNNF)$1.18B revenue · FY2025
- UroGen Pharma Ltd. (URGN)$110M revenue · FY2025
- Adma Biologics, Inc. (ADMA)$510M revenue · FY2025
- Zenas BioPharma, Inc. (ZBIO)$10.0M revenue · FY2025
- Aurinia Pharmaceuticals Inc. (AUPH)$283M revenue · FY2025
- NovoCure Ltd (NVCR)$655M revenue · FY2025
- Zymeworks Inc. (ZYME)$106M revenue · FY2025
- PERRIGO Co plc (PRGO)$4.25B revenue · FY2025
- Vericel Corp (VCEL)$276M revenue · FY2025
- Progyny, Inc. (PGNY)$1.29B revenue · FY2025
- Xencor Inc (XNCR)$126M revenue · FY2025
- Agios Pharmaceuticals, Inc. (AGIO)$54.0M revenue · FY2025
- Recursion Pharmaceuticals, Inc. (RXRX)$74.7M revenue · FY2025
- Vir Biotechnology, Inc. (VIR)$68.6M revenue · FY2025
- Stoke Therapeutics, Inc. (STOK)$184M revenue · FY2025
- Butterfly Network, Inc. (BFLY)$97.6M revenue · FY2025
- Nanobiotix S.A. (NBTX)EUR 32.6M revenue · FY2025
- Lakefront Biotherapeutics NV (LKFT)EUR 1.11B revenue · FY2025
- Surgery Partners, Inc. (SGRY)$3.31B revenue · FY2025
- Immunocore Holdings plc (IMCR)$400M revenue · FY2025
- Damora Therapeutics, Inc. (DMRA)$0.00 revenue · FY2025
- Lemaitre Vascular Inc (LMAT)$250M revenue · FY2025
- COMPASS Pathways plc (CMPS)$0.00 revenue · FY2025
- Personalis, Inc. (PSNL)$69.6M revenue · FY2025
- Syndax Pharmaceuticals Inc (SNDX)$172M revenue · FY2025
- Taysha Gene Therapies, Inc. (TSHA)$9.77M revenue · FY2025
- Inspire Medical Systems, Inc. (INSP)$912M revenue · FY2025
- Sonida Senior Living, Inc. (SNDA)$381M revenue · FY2025
- Intellia Therapeutics, Inc. (NTLA)$67.7M revenue · FY2025
- Inhibrx Biosciences, Inc. (INBX)$1.30M revenue · FY2025
- GH Research PLC (GHRS)$0.00 revenue · FY2025
- ANI Pharmaceuticals Inc (ANIP)$12.5M revenue · FY2025
- Biolife Solutions Inc (BLFS)$96.2M revenue · FY2025
- Septerna, Inc. (SEPN)$46.0M revenue · FY2025
- Tyra Biosciences, Inc. (TYRA)$0.00 revenue · FY2025
- Ascentage Pharma Group International (ASPHF)CNY 574M revenue · FY2025
- Novavax Inc (NVAX)$1.12B revenue · FY2025
- Fortrea Holdings Inc. (FTRE)$2.72B revenue · FY2025
- Eton Pharmaceuticals, Inc. (ETON)$80.0M revenue · FY2025
- Alvotech (ALVO)$586M revenue · FY2025
- Anaptysbio, Inc (ANAB)$235M revenue · FY2025
- Ascentage Pharma Group International (AAPG)CNY 574M revenue · FY2025
- Forte Biosciences, Inc. (FBRX)$0.00 revenue · FY2025
- LB Pharmaceuticals Inc (LBRX)$0.00 revenue · FY2025
- Xeris Biopharma Holdings, Inc. (XERS)$292M revenue · FY2025
- Phibro Animal Health Corp (PAHC)$1.52B revenue · FY2026
- Innoviva, Inc. (INVA)$21.1M revenue · FY2025
- Ardent Health, Inc. (ARDT)$6.32B revenue · FY2025
- Bicara Therapeutics Inc. (BCAX)$0.00 revenue · FY2025
- ArriVent BioPharma, Inc. (AVBP)$0.00 revenue · FY2025
- Viridian Therapeutics, Inc.\DE (VRDN)$70.8M revenue · FY2025
- Absci Corp (ABSI)$2.80M revenue · FY2025
- Ultragenyx Pharmaceutical Inc. (RARE)$673M revenue · FY2025
- Schrodinger, Inc. (SDGR)$256M revenue · FY2025
- Healthcare Services Group Inc (HCSG)$1.84B revenue · FY2025
- Kestra Medical Technologies, Ltd. (KMTS)$95.1M revenue · FY2026
- Aktis Oncology, Inc. (AKTS)$6.50M revenue · FY2025
- agilon health, inc. (AGL)$5.93B revenue · FY2025
- Vor Biopharma Inc. (VOR)$0.00 revenue · FY2025
- CONMED Corp (CNMD)$1.37B revenue · FY2025
- Alphatec Holdings, Inc. (ATEC)$764M revenue · FY2025
- InnovAge Holding Corp. (INNV)$854M revenue · FY2025
- SL Science Holding Ltd (SLBT)$2.20M revenue · FY2025
- Maze Therapeutics, Inc. (MAZE)$0.00 revenue · FY2025
- Harrow, Inc. (HROW)$272M revenue · FY2025
- Cullinan Therapeutics, Inc. (CGEM)$0.00 revenue · FY2025
- Alumis Inc. (ALMS)$24.1M revenue · FY2025
- Replimune Group, Inc. (REPL)$0.00 revenue · FY2026
- Alto Neuroscience, Inc. (ANRO)$0.00 revenue · FY2025
- Omada Health, Inc. (OMDA)$260M revenue · FY2025
- Tandem Diabetes Care Inc (TNDM)$1.01B revenue · FY2025
- Omeros Corp (OMER)$0.00 revenue · FY2025
- MeiraGTx Holdings plc (MGTX)$81.4M revenue · FY2025
- Oric Pharmaceuticals, Inc. (ORIC)$0.00 revenue · FY2025
- Pennant Group, Inc. (PNTG)$948M revenue · FY2025
- National Vision Holdings, Inc. (EYE)$1.99B revenue · FY2026
- Alpha Tau Medical Ltd. (DRTS)$0.00 revenue · FY2025
- Mannkind Corp (MNKD)$349M revenue · FY2025
- PROCEPT BioRobotics Corp (PRCT)$308M revenue · FY2025
- Integra Lifesciences Holdings Corp (IART)$1.64B revenue · FY2025
- Herbalife Ltd. (HLF)$5.04B revenue · FY2025
- Immatics N.V. (IMTX)EUR 48.3M revenue · FY2025
- MoonLake Immunotherapeutics (MLTX)$0.00 revenue · FY2025
- Cadre Holdings, Inc. (CDRE)$610M revenue · FY2025
- Jade Biosciences, Inc. (JBIO)$0.00 revenue · FY2025
- Evaxion A/S (EVAX)$7.53M revenue · FY2025
- Artivion, Inc. (AORT)$441M revenue · FY2025
- Janux Therapeutics, Inc. (JANX)$10.0M revenue · FY2025
- Opko Health, Inc. (OPK)$607M revenue · FY2025
- Trupanion, Inc. (TRUP)$1.44B revenue · FY2025
- Corvus Pharmaceuticals, Inc. (CRVS)$0.00 revenue · FY2025
- Cronos Group Inc. (CRON)$147M revenue · FY2025
- U S Physical Therapy Inc (USPH)$781M revenue · FY2025
- Monte Rosa Therapeutics, Inc. (GLUE)$124M revenue · FY2025
- Kura Oncology, Inc. (KURA)$67.5M revenue · FY2025
- Staar Surgical Co (STAA)$239M revenue · FY2026
- Attovia Therapeutics, Inc. (ATTO)$1.35M revenue · FY2025
- Sana Biotechnology, Inc. (SANA)$0.00 revenue · FY2025
- Teladoc Health, Inc. (TDOC)$2.53B revenue · FY2025
- LifeMD, Inc. (LFMDP)$194M revenue · FY2025
- Valneva SE (VALN)EUR 175M revenue · FY2025
- Savara Inc (SVRA)$0.00 revenue · FY2025
- Solid Biosciences Inc. (SLDB)$0.00 revenue · FY2025
- Maravai Lifesciences Holdings, Inc. (MRVI)$186M revenue · FY2025
- Enovis CORP (ENOV)$2.25B revenue · FY2025
- Iradimed Corp (IRMD)$83.8M revenue · FY2025
- Pacira BioSciences, Inc. (PCRX)$726M revenue · FY2025
- Faeth Therapeutics, Inc. (FTH)$0.00 revenue · FY2025
- Avalo Therapeutics, Inc. (AVTX)$59.0K revenue · FY2025
- Arbutus Biopharma Corp (ABUS)$14.1M revenue · FY2025
- Geron Corp (GERN)$184M revenue · FY2025
- Castle Biosciences Inc (CSTL)$344M revenue · FY2025
- Lexicon Pharmaceuticals, Inc. (LXRX)$49.8M revenue · FY2025
- Immix Biopharma, Inc. (IMMX)$0.00 revenue · FY2025
- Amphastar Pharmaceuticals, Inc. (AMPH)$720M revenue · FY2025
- Alterity Therapeutics Ltd (ATHE)$981M market cap
- Annexon, Inc. (ANNX)$0.00 revenue · FY2025
- Candel Therapeutics, Inc. (CADL)$0.00 revenue · FY2025
- SpyGlass Pharma, Inc. (SGP)$0.00 revenue · FY2025
- QuidelOrtho Corp (QDEL)$2.73B revenue · FY2025
- Wave Life Sciences, Inc. (WVE)$42.7M revenue · FY2025
- Bioventus Inc. (BVS)$568M revenue · FY2025
- Ceribell, Inc. (CBLL)$89.1M revenue · FY2025
- Design Therapeutics, Inc. (DSGN)$0.00 revenue · FY2025
- InMode Ltd. (INMD)$370M revenue · FY2025
- Ardelyx, Inc. (ARDX)$407M revenue · FY2025
- Olema Pharmaceuticals, Inc. (OLMA)$0.00 revenue · FY2025
- Inventiva S.A. (IVA)EUR 4.48M revenue · FY2025
- Rigel Pharmaceuticals Inc (RIGL)$294M revenue · FY2025
- Aclaris Therapeutics, Inc. (ACRS)$7.83M revenue · FY2025
- Climb Bio, Inc. (CLYM)$0.00 revenue · FY2025
- Theravance Biopharma, Inc. (TBPH)$107M revenue · FY2025
- AdaptHealth Corp. (AHCO)$3.24B revenue · FY2025
- Anteris Technologies Global Corp. (AVR)$1.91M revenue · FY2025
- Beta Bionics, Inc. (BBNX)$100M revenue · FY2025
- Achieve Life Sciences, Inc. (ACHV)$0.00 revenue · FY2025
- SI-BONE, Inc. (SIBN)$201M revenue · FY2025
- CytomX Therapeutics, Inc. (CTMX)$76.2M revenue · FY2025
- Glass House Brands Inc. (GLAS)$182M revenue · FY2025
- Pharming Group N.V. (PHAR)$376M revenue · FY2025
- Cryoport, Inc. (CYRX)$176M revenue · FY2025
- Adlai Nortye Group Ltd. (ANL)$5.00M revenue · FY2025
- Nuvectis Pharma, Inc. (NVCT)$0.00 revenue · FY2025
- Monopar Therapeutics (MNPR)$0.00 revenue · FY2025
- Aura Biosciences, Inc. (AURA)$0.00 revenue · FY2025
- Pharming Group N.V. (PHGUF)$376M revenue · FY2025
- Crescent Biopharma, Inc. (CBIO)$10.8M revenue · FY2025
- Neurogene Inc. (NGNE)$0.00 revenue · FY2025
- Phathom Pharmaceuticals, Inc. (PHAT)$175M revenue · FY2025
- Collegium Pharmaceutical, Inc (COLL)$781M revenue · FY2025
- Gyre Therapeutics, Inc. (GYRE)$117M revenue · FY2025
- Greenland Mines Ltd (GRML)$0.00 revenue · FY2025
- Assembly Biosciences, Inc. (ASMB)$72.3M revenue · FY2025
- 4D Molecular Therapeutics, Inc. (FDMT)$85.2M revenue · FY2025
- Verastem, Inc. (VSTM)$30.9M revenue · FY2025
- Oculis Holding AG (OCS)CHF 0.00 revenue · FY2025
- Zevra Therapeutics, Inc. (ZVRA)$106M revenue · FY2025
- BridgeBio Oncology Therapeutics, Inc. (BBOT)$0.00 revenue · FY2025
- Ironwood Pharmaceuticals Inc (IRWD)$296M revenue · FY2025
- Silence Therapeutics plc (SLN)$559K revenue · FY2025
- SS Innovations International, Inc. (SSII)$42.5M revenue · FY2025
- Shattuck Labs, Inc. (STTK)$1.00M revenue · FY2025
- Allogene Therapeutics, Inc. (ALLO)$0.00 revenue · FY2025
- Prime Medicine, Inc. (PRME)$4.63M revenue · FY2025
- Aquestive Therapeutics, Inc. (AQST)$44.5M revenue · FY2025
- Mimedx Group, Inc. (MDXG)$419M revenue · FY2025
- Altimmune, Inc. (ALT)$41.0K revenue · FY2025
- Evotec SE (EVO)EUR 788M revenue · FY2025
- CorMedix Inc. (CRMD)$312M revenue · FY2025
- OmniAb, Inc. (OABI)$18.7M revenue · FY2025
- Angiodynamics Inc (ANGO)$320M revenue · FY2026
- Valneva SE (INRLF)EUR 175M revenue · FY2025
- Concord Medical Services Holdings Ltd (CCM)CNY 461M revenue · FY2025
- Evolus, Inc. (EOLS)$297M revenue · FY2025
- Arvinas, Inc. (ARVN)$263M revenue · FY2025
- Tilray Brands, Inc. (TLRY)$915M revenue · FY2026
- Cytek Biosciences, Inc. (CTKB)$201M revenue · FY2025
- Starling Oncology, Inc. (STLN)$503M revenue · FY2025
- Tectonic Therapeutic, Inc. (TECX)$0.00 revenue · FY2025
- Chemomab Therapeutics Ltd. (CMMB)$0.00 revenue · FY2025
- Zura Bio Ltd (ZURA)$0.00 revenue · FY2025
- Autolus Therapeutics plc (AUTL)$75.4M revenue · FY2025
- Fortress Biotech, Inc. (FBIOP)$63.3M revenue · FY2025
- REGENXBIO Inc. (RGNX)$170M revenue · FY2025
- Cabaletta Bio, Inc. (CABA)$0.00 revenue · FY2025
- Orthopediatrics Corp (KIDS)$236M revenue · FY2025
- Prokidney Corp. (PROK)$893K revenue · FY2025
- MapLight Therapeutics, Inc. (MPLT)$0.00 revenue · FY2025
- Delcath Systems, Inc. (DCTH)$85.2M revenue · FY2025
- Addex Therapeutics Ltd. (ADXN)CHF 30.0K revenue · FY2025
- ARS Pharmaceuticals, Inc. (SPRY)$84.3M revenue · FY2025
- Immunic, Inc. (IMUX)$0.00 revenue · FY2025
- Brainsway Ltd. (BWAY)$52.2M revenue · FY2025
- Artiva Biotherapeutics, Inc. (ARTV)$0.00 revenue · FY2025
- Capricor Therapeutics, Inc. (CAPR)$0.00 revenue · FY2025
- Fulgent Genetics, Inc. (FLGT)$323M revenue · FY2025
- Agomab Therapeutics NV (AGMB)EUR 0.00 revenue · FY2025
- BlossomHill Therapeutics, Inc. (BLSM)$0.00 revenue · FY2025
- Cerus Corp (CERS)$234M revenue · FY2025
- NeuroPace Inc (NPCE)$100.0M revenue · FY2025
- Kyverna Therapeutics, Inc. (KYTX)$0.00 revenue · FY2025
- Prothena Corp Public Ltd Co (PRTA)$9.68M revenue · FY2025
- Editas Medicine, Inc. (EDIT)$40.5M revenue · FY2025
- Tactile Systems Technology Inc (TCMD)$330M revenue · FY2025
- Puma Biotechnology, Inc. (PBYI)$228M revenue · FY2025
- Kamada Ltd (KMDA)$180M revenue · FY2025
- NovaBridge Biosciences (NBP)CNY 0.00 revenue · FY2025
- NRC Health (NRC)$137M revenue · FY2025
- Relmada Therapeutics, Inc. (RLMD)$0.00 revenue · FY2025
- Strata Critical Medical, Inc. (SRTA)$197M revenue · FY2025
- Atea Pharmaceuticals, Inc. (AVIR)$0.00 revenue · FY2025
- C4 Therapeutics, Inc. (CCCC)$35.9M revenue · FY2025
- Ocugen, Inc. (OCGN)$4.41M revenue · FY2025
- Sight Sciences, Inc. (SGHT)$77.4M revenue · FY2025
- Arcturus Therapeutics Holdings Inc. (ARCT)$82.0M revenue · FY2025
- Evommune, Inc. (EVMN)$13.0M revenue · FY2025
- Rezolute, Inc. (RZLT)$0.00 revenue · FY2025
- BioAge Labs, Inc. (BIOA)$8.99M revenue · FY2025
- Prelude Therapeutics Inc (PRLD)$12.1M revenue · FY2025
- Benitec Biopharma Inc. (BNTC)$0.00 revenue · FY2025
- Fennec Pharmaceuticals Inc. (FENC)$44.6M revenue · FY2025
- Ginkgo Bioworks Holdings, Inc. (DNA)$170M revenue · FY2025
- Quoin Pharmaceuticals, Ltd. (QNRX)$0.00 revenue · FY2025
- Prenetics Global Ltd (PRE)$92.4M revenue · FY2025
- Compass Therapeutics, Inc. (CMPX)$0.00 revenue · FY2025
- Carlsmed, Inc. (CARL)$50.5M revenue · FY2025
- ClearPoint Neuro, Inc. (CLPT)$37.0M revenue · FY2025
- Rocket Pharmaceuticals, Inc. (RCKT)$0.00 revenue · FY2025
- SBC Medical Group Holdings Inc (SBC)$174M revenue · FY2025
- Shoulder Innovations, Inc. (SI)$47.3M revenue · FY2025
- Pacific Biosciences Of California, Inc. (PACB)$160M revenue · FY2025
- 908 Devices Inc. (MASS)$56.2M revenue · FY2025
- Canopy Growth Corp (CGC)CAD 285M revenue · FY2026
- Enanta Pharmaceuticals Inc (ENTA)$65.3M revenue · FY2025
- Community Health Systems Inc (CYH)$12.5B revenue · FY2025
- Lexeo Therapeutics, Inc. (LXEO)$0.00 revenue · FY2025
- X4 Pharmaceuticals, Inc (XFOR)$6.50M revenue · FY2025
- Larimar Therapeutics, Inc. (LRMR)$0.00 revenue · FY2025
- EyePoint, Inc. (EYPT)$31.4M revenue · FY2025
- Opus Genetics, Inc. (IRD)$14.2M revenue · FY2025
- Auna S.A. (AUNA)PEN 4.39B revenue · FY2025
- Contineum Therapeutics, Inc. (CTNM)$0.00 revenue · FY2025
- Century Therapeutics, Inc. (IPSC)$109M revenue · FY2025
- Orthofix Medical Inc. (OFIX)$822M revenue · FY2025
- SNDL Inc. (SNDL)CAD 946M revenue · FY2025
- Alpha Teknova, Inc. (TKNO)$40.5M revenue · FY2025
- Agenus Inc (AGEN)$114M revenue · FY2025
- Palisade BIO, Inc. (PALI)$0.00 revenue · FY2025
- DiaMedica Therapeutics Inc. (DMAC)$0.00 revenue · FY2025
- Perspective Therapeutics, Inc. (CATX)$0.00 revenue · FY2025
- Q32 Bio Inc. (QTTB)$53.7M revenue · FY2025
- Lyell Immunopharma, Inc. (LYEL)$36.0K revenue · FY2025
- Inhibikase Therapeutics, Inc. (IKT)$0.00 revenue · FY2025
- AVITA Medical, Inc. (RCEL)$71.6M revenue · FY2025
- Viemed Healthcare, Inc. (VMD)$270M revenue · FY2025
- Abeona Therapeutics Inc. (ABEO)$5.82M revenue · FY2025
- Anbio Biotechnology (NNNN)$8.65M revenue · FY2025
- SAB Biotherapeutics, Inc. (SABS)$0.00 revenue · FY2025
- Sagimet Biosciences Inc. (SGMT)$0.00 revenue · FY2025
- Sutro Biopharma, Inc. (STRO)$102M revenue · FY2025
- Upstream Bio, Inc. (UPB)$2.85M revenue · FY2025
- Embecta Corp. (EMBC)$1.08B revenue · FY2025
- Vanda Pharmaceuticals Inc. (VNDA)$216M revenue · FY2025
- Jin Medical International Ltd. (ZJYL)$20.7M revenue · FY2025
- Sionna Therapeutics, Inc. (SION)$0.00 revenue · FY2025
- Pyxis Oncology, Inc. (PYXS)$13.9M revenue · FY2025
- Sanara MedTech Inc. (SMTI)$103M revenue · FY2025
- Emergent BioSolutions Inc. (EBS)$743M revenue · FY2025
- Treace Medical Concepts, Inc. (TMCI)$213M revenue · FY2025
- Immuneering Corp (IMRX)$0.00 revenue · FY2025
- TriSalus Life Sciences, Inc. (TLSI)$45.2M revenue · FY2025
- Orchestra BioMed Holdings, Inc. (OBIO)$33.5M revenue · FY2025
- Myriad Genetics Inc (MYGN)$825M revenue · FY2025
- Galectin Therapeutics Inc (GALT)$0.00 revenue · FY2025
- Bicycle Therapeutics PLC (BCYC)$72.6M revenue · FY2025
Other sectors
Or browse A–Z by ticker, by exchange or head-to-head comparisons.